, , , . , , 10-15% . 4-5 .
:
- - (PCR, PCR real time, )
- ( IgM, G; , , .). G , , , IgG.
- () ( ).
- ( ).
, , . real-time .
:
- : ( ), (+), , ; )
-: /; .
:
- (- );
- IgM ;
- IgG =IgG /IgG )
!
:
1) ,
2) ,
3) ,
4) ,
5) , ,
6) ,
7) IgM ,
8) IgG ,
9) 2-4 IgG 2 .
.
.
:
- - (, , , , .) .
- ;
- IgM;
- C IgG 3 .
7.
|
|
|
| / | ||
| SV-1 | - (, real time) | , , |
| , , | ||
| () | IgM IgG - , , | |
| HSV-2 | - (, real time) | , , , |
| 2. | , , | |
| 3. (, ) | , : IgM - , Ig G - , IgG, . 3 - IgG 2 , . | |
| VVZ | 1. , real time | , , |
| 2. | , , | |
| 3. ( , - , ) | , : IgM, IgG , IgG * | |
| EBV | 1. , real time | , , |
| 2. | , , | |
| 3. (, ) | IgM (VCA), IgG (VCA) - , , IgG. | |
| HHV-6 | 1. , real time | , , |
| 2. | , , | |
| 3. () | IgM, IgG - , , IgG. | |
| MV | 1. , real time | , , , |
| 2. | , , | |
| 3. | , : IgM - , Ig G - , IgG, . - 3 . - IgG 2 , . | |
| Tick born encephalitis | 1. | , IgM |
| 2. - (, real time) | , | |
| Enterovirus | 1. - (, real time) | , |
| 2. () | , |
* 2 -3 ( 2-4 , 1- ).
:
- .
- ().
, (. 6), - , FLAIR / 2-, .
|
|
|
8.
| : Borrelia burdgorferi s.l, mycobacterium tuberculosis, mycoplasma, chlamidia, listeria monocytogenes),bartonella henselae, brucella melitensis), treponema pallidum, tropherima Whipplei, Streptococci , | - , -, , -. - |
| , , , : rickettsia rickettsia, coxiella burnetti, erlichia chaffeensis, anaplasma phagocytophilum. | , -, . |
| , (, , , , ). | , , , , . |
| - (toxoplasma gondi), (trypanosoma brucei gambiense); (Plasmodium falciparum), (Naegleria fowleri). | - ; |
| (taenia solium); ( echinococcus granulosus), (gnathostoma species). | - , , - ; - |
| , , . | - , , . |
| -, , , , | - - - |
| , : (c), - (), ( ), , ( ), , . | - - - - |
| , (, ). | - : -Yo, Hu, Ri, Hodgkin AK), |
| ( ), -, , , . | - , . |
| . | - . |
| (, .) - | -, 11-, , - ; |
| - ( , IgG)* | |
| (- , - , - ) | , ; . |
* 13 , ( 10 ), ; ( 2).
|
|
|
/ .
IX.
, .
.
10 / 3 8 / -α2 -α2 . , .
9.
| (1 ) | (2 ) | |
| SV | Acyclovir + -α2 or Acyclovir 10 / 3 / 10-14 ( ) | Valacyclovir, Gancyclovir, Foscarnet* ( ) |
| VVZ | Acyclovir + -α2 or Acyclovir 10-15 / 3 / 10-14 ( B) | Valacyclovir, Gancyclovir Foscarnet, Famcyclovir |
| CMV | Gancyclovir + Interferon- alpha2 or Gancyclovir +Foscarnet or Gancyclovir 5 / 2 14-21 Foscarnet 10-14 ( B) | IVIG (Neocytotec) |
| HHV-6 | Gancyclovir ( B) | Foscarnet 10-14 |
| EBV | Famcyclovir 10-20 // 2-3 10 + Interferon- alpha2 ( ) | IVIG (Intratect, Octagam) |
| Measles | Ribavirin | |
| Rubella | Amantadin hydrohlorid | |
| Influenza | Oseltamivir ( ) | Rimantadin |
| Nipah virus | Ribavirin | |
| Tick born encephalitis virus | 1 . Ribavirin 10 / 2-3 20-30 +Interferon- alpha2 ( ) 2 . Ayaferon 1 .3 1 ( ) | Panavir 5 1 / 5 |
| West Nile virus | Ribavirin 10 // ( ) | |
| Enterovirus | Ribavirin 10 // 14 + Interferon alpha2 Cikloferon 6-10 // / / 7-10 ( ) | Pleconaril |
| Adenovirus | Ribavirin |
-α2 : 2-4 , 3 , 6 .
, .
.
1. ( ).
- : 1 / 4 - ( ) 10-20 / 1 ) 3-5 .
|
|
|
- ( 0,25-0,5 /) () 1-2 / 30-40 .
- (75% ).
2. ( ), ( / 50 // 1 5-7, 2 ), - . 13.
:
-
- - .
3. :
- - (- 10-20 / 1 , 1 ) 3 ;
- ( 1-2 3-4 1/3 ) ;
- IL-2 / . 0,5 3-5 1 3-5 ( ) ( );
- G (, ) 100-200 / - 300-400 / - 1 2-5.
:
- , :
- .
IL-2 .
.
5- . / . 1 /5/ 10-14 , 50 // 1-1,5 .
5-15 / 1 .
( ).
( 10% 50-70 // 3 1.5-2 ( ).
(1, 6, 12, ) 1,5-2 ( ).
, , (). 30 1 . 10 3 ( 5 . 3 ). 1-3 ( ).
0,6 / ( 10 ) 1 / 0,5% 5-7 .
, , / 7-10, ( ).
( 2-3 //) 2-4 10 / 2 2-4 ( ).
.
, .
6-15 /- 5 () , -1-2 // ( 30 //), 2500 . (, , )- 20-40 //c.
10.
| ( ) | ||
| 1. (= = =) | ||
| 2. - () | ||
| 3. ( = ) | ||
| 4. (, ) | ||
| 5. , (, , , , ) | , | |
| 6. () | + + ( ) + , . | |
| 7. - (-= ) | ||
| 8. - . | ||
| 9. ( + ++ ) | ||
| 1. (, ) | , + , | |
| 2. (, ) | ||
| 3. , , , () | ||
| 4. | ||
| 5. | ||
| 1., () | - | |
| 2. | ||
| 1. (= = ) | ||
| 2. , () | ||
| 3., . () | ||
|
|
|
, 20-40 //. (30 /) 3-5 / .
11.
(1 )
| N / | - (-) | - | |
| . . | 3- 5 . . | - - 1- - 1 ., 1 3 .; 2-3- 1 6 ., 4-5 1 . . -, - 1 , |
12.
(2 )
| N / | , | - . | , , , . | |
| - / 1,5-2 ( ) - - 3 ., 12 . - . - ( ) 60 , 12 ., . - , 3 , 12 ., . | 2-4 . - , , 2-4 . - - 1 ( , 3 ). | ; - , ; - ( ) , | . - |
| () -α2 ( / ) | ( . ) | ||
| ( . ) | |||
| ( . ) | |||
| , | ( . ) | ||
| , | -α2 | () | . |
| -α2 | ( . ) | ||
| (, -α2 ) | ( . ) | ||
| , | 1 20 /- 20 ( / ) | () , ) | - |
| () | - | ||
| () | - | ( ) |
( , , , ) - .
. .- 2- . . / . .. .- .: , 2009. 832
.., . ., .. // 2348411. 10.03.2009.
( -2) / // . . .. .- : .,2010. - 60.
.., .., .., .. / 229528. 20.03.2007.
, , . (, , , , ) , C.:.,2012.- 80c
.., .., .. . : : - -, 2011. - 48.
.., .., .. : . .: .,2012- 432.
(, , , , , ): / . .. .:,2009. - 96 .
.., .. : / .: - , 2008. 424 C.
.., .., .., .. : . / // , : . . . - .I. - , 2011. - . 6-17.
.., .. : . / , : . . . - .I. - , 2011. - . 18-29.
.., .. . . : . .. . / // : , 2007. - C. 860-877.
.., .., .. . / . , 2009. . 54.- 3. - . 38-55.
.., .., .., .. // 2407449. 27.12.2010.
.., ., .., .. // 2372839. 20.11.2009.
.., , .., .. / . , 2009. .1, 4. . 36-43.
.., .., .. . (, , , ). .- .: , 2013.- 44.
, , . () . , 2012.- 2-3. - . 58-69.
.., .., .. . / -. , 4, 2012.- .37-47.
.., ..,, . . /. // . , 2007. . V. 1. . 27-32.
.., .., .. - / // . , 2007. V, 3-4. - . 27-32.
.., .., . . .:, 2011. - 56.
Agin H, Apa H, Unalp A, Kayserili E. Acute disseminated encephalomyelitis associated with enteroviral infection. Neurosciences (Riyadh) 2010;15: 4648.
Casiraghi, C. Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis / C. Casiraghi, K. Dorovini-Zis, M.S. Horwitz // J Neuroimmunol. 2011. V.230. P.173177.
Douvoyiannis, M. Neurologic manifestations associated with parvovirus B19 infection / M. Douvoyiannis, N. Litman, D.L. Goldman // Clin Infect Dis. 2009. V.48. - 12. P. 1713-1723.
Fujimoto H. Epstein-Barr virus infections of the central nervous system.- Intern. Med. - 2013; 42(1); 33-40
Rhoades Ross E., Tabor-Godwin Jenna M., Tsueng Ginger, Feuer Ralph Enterovirus Infections of the Central Nervous System Virology. 2011 March 15; 411(2): 288305.
Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010 Aug; 17(8):999-e57.
Tunkel A.K., Glasser C.A, Bloch K.C., et al. The management of encephalitis clinical practice guidelines by the infectious diseases Society of America / Cl. Infectious Disease. 2008. - V.47. - P.303-327.
Spalice . Clinical and Pharmacological Aspects of Inflammatory Demye-linating Diseases in Childhood: An Update / . Spalice, P. Parisi, L. Papetti, [et al.] // Curr Neuropharmacol. 2010. V.8. - 2. .135148.
Feasby T. Guidelines on the use of intravenous immune globulin for neurologic conditions / Feasby T., Banwell B., Benstead T., [et al.] // Transfus Med Rev. 2007. V. 21 (Suppl. 1). P. 57-107.
XIII.
()
, , ,
, :
:
- ;
- ;
- ;
- (, ):
, :
- , ;
- , .
:
- , ;
- , ():
:
- , (, );
- , , .
, (, , , , ), :
- ;
- ( , , , );
- /.
()
